Revance Therapeutics | 현금 및 동등한

Cash And Equivalent 변화 날짜
AbbVie USD 13.29B 4.53B 2023-09
ALKERMES USD 647.71M 18.08M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Cara Therapeutics USD 62.88M 4.63M 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Merck USD 8.6B 2.94B 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pacira USD 153.3M 54.18M 2023-12
Revance Therapeutics USD 179.32M 38.08M 2023-09
Supernus Pharmaceuticals USD 75.05M 19.93M 2023-12



Revance Therapeutics 현금 및 동등한 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.